Wartość EBITDA organizacji Cigna Group (The) to $10.716B
EBITDA to zysk firmy przed odliczeniem odsetek, podatków, amortyzacji i jest miarą księgową obliczoną na podstawie zarobków netto firmy, przed odliczeniem kosztów odsetek, podatków, amortyzacji i odliczeniem, jako wskaźnika bieżącej rentowności operacyjnej spółki.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.